MetaADEDB 2.0 @ LMMD
Otosclerosis
(UMLS:C0029899)
Definition:
Formation of spongy bone in the labyrinth capsule which can progress toward the STAPES (stapedial fixation) or anteriorly toward the COCHLEA leading to conductive, sensorineural, or mixed HEARING LOSS. Several genes are associated with familial otosclerosis with varied clinical signs.
UMLS ID:
C0029899
MeSH ID:
D010040
Classification:
Name:
Otorhinolaryngologic Diseases
MeSH Tree Number(s):
C09.218.768
Synonym(s)
1.
Otosclerosis
2.
OTOSCLEROSIS
3.
Otosclerosis syndrome
4.
Otosclerosis, NOS
5.
Otosclerosis, unspecified
6.
Otospongiosis
7.
Otospongiosis syndrome
8.
Otospongiosis, NOS
9.
Unspecified otosclerosis, unspecified ear
10.
otoscleroses
11.
otosclerosis
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1NorgestrelFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
2Zoledronic AcidFAERS: 3US FAERS
3AlendronateFAERS: 2US FAERS
4BromocriptineFAERS: 2US FAERS
5LatanoprostFAERS: 2US FAERS
6TeriparatideFAERS: 2US FAERS
7ValsartanFAERS: 2US FAERS
8EstradiolFAERS: 1US FAERS
9Estrogens, Conjugated (USP)FAERS: 1US FAERS
10FluvoxamineFAERS: 1US FAERS
11LisinoprilFAERS: 1US FAERS
12Norethindrone acetate and ethinyl estradiolFAERS: 1US FAERS
13Ortho EvraFAERS: 1US FAERS
14RivaroxabanFAERS: 1US FAERS
15Rosuvastatin CalciumFAERS: 1US FAERS
16acetaminophen, aspirin, caffeine drug combinationFAERS: 1US FAERS
17candesartan cilexetilFAERS: 1US FAERS
18estradiol, norethindrone drug combinationFAERS: 1US FAERS
19norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combinationFAERS: 1US FAERS
20sibutramineFAERS: 1US FAERS
21AcebutololOFFSIDES
22BupropionOFFSIDES
23ChloroquineOFFSIDES
24PantoprazoleOFFSIDES
25Raloxifene HydrochlorideOFFSIDES
26rizatriptanOFFSIDES
27rizatriptanOFFSIDES
Similar ADE(s)
NameSemantic Similarity
1Tympanosclerosis42.9%
2Labyrinthitis40.9%
3Cochlear Diseases31%
4Otitis Externa31%
5Otitis Media31%
6Vestibular Diseases31%
7Endolymphatic Hydrops31%
8Tympanic Membrane Perforation30%
9Otomycosis28.6%
10Congenital Microtia28.6%
11Ear Neoplasms27.8%
12Meniere Disease25.4%
13Otitis Media with Effusion25.4%
14Vestibulocochlear Nerve Diseases20.9%
15Dysacusis20.5%
16Vestibular Neuronitis16.9%
17Herpes Zoster Oticus16.3%
18Laryngeal Diseases15.8%
19Nose Diseases15.8%
20Pharyngeal Diseases15.8%
21Hyperacusis14.9%
22Tinnitus14.9%
23Phonophobia14.9%
24Hearing Loss14.9%
25Vertigo12.8%
26Mastoiditis12.4%
27Petrositis12.4%
28Deafness12.3%
29Hearing Loss, Sudden12.3%
30Hearing Loss, Bilateral12.3%
31Hearing Loss, High-Frequency12.3%
32Hearing Loss, Mixed Conductive-Sensorineural12.3%
33Hearing Loss, Unilateral12.3%
34Complete Hearing Loss12.3%
35Deaf Mutism12.3%
36Pharyngeal Neoplasms11.2%
37Granuloma, Lethal Midline9.5%
38Laryngeal Edema9.5%
39Nose Deformities, Acquired9.5%
40Laryngeal neoplasm9.4%
41Deglutition Disorders9.3%
42Primary Ciliary Dyskinesia8.8%
43Nasopharyngeal Neoplasms8.6%
44Hypopharyngeal Neoplasms8%
45Hypopharyngeal Cancer8%
46Acoustic Neuroma7.5%
47Paranasal Sinus Neoplasms7.5%
48Laryngitis7.1%
49Pharyngitis7.1%
50Rhinitis7.1%
51Vocal Cord Dysfunction7.1%
52Auditory Perceptual Disorders7.1%
53Laryngostenosis7%
54Nasal Polyps7%
55Nose Neoplasms6.9%
56Croup6.8%
57Rhinitis, Vasomotor6.8%
58Nasopharyngitis6.7%
59Tonsillar Neoplasms6.5%
60Maxillary Sinus Neoplasms6.1%
61Nasopharyngeal carcinoma6.1%
62Choanal Atresia5.6%
63Voice Disorders5.6%
64Voice Disturbance5.6%
65Laryngocele5.6%
66Epistaxis5.6%
67Sinusitis5.2%
68Laryngospasm5.1%
69Tonsillitis5.1%
70Laryngomalacia4.7%
71Granuloma, Laryngeal4.6%
72Vocal Cord Paralysis4.6%
73Aphonia4%
74Retropharyngeal Abscess4%
75Dysphonia4%
76Lemierre Syndrome3.8%
77Rhinoscleroma3.4%
78Hay fever3.3%
79Rhinitis, Allergic, Perennial3.3%
80Peritonsillar Abscess3.3%
81Hoarseness2.9%
82Kartagener Syndrome2.1%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.